Camlin Fine Sciences enters into JV agreement with Pahang Pharma

02 Apr 2018 Evaluate

Camlin Fine Sciences has entered into a joint venture (JV) agreement with Pahang Pharma (S), a company duly incorporated under the laws of Singapore. The proposed term of the joint venture is 30 years with investment in holding company in the proportion of 51% by the company and 49% by Pahang Pharma (S).

The purpose of entering into agreement is for incorporating a company in Singapore who shall be holding company for its subsidiary(ies) which shall be incorporated in ASEAN countries as per the business model basically to engage in research, development, production, trade and dealing in animal feed ingredients and animal feed nutrition products viz. Antioxidants, binders, acidifiers, stabilizers, disinfectants etc.

Camlin Fine Sciences is the world's second largest manufacturer and marketer of food grade antioxidants BHA (butylated hydroxyanisole) and TBHQ (Tertiary Butylhydroquinone).

Camlin Fine Sciences Share Price

155.55 0.65 (0.42%)
19-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3899.65
Tata Chemicals 761.20
SRF 3090.15
Pidilite Inds. 1459.30
Deepak Nitrite 1666.40
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×